| ²é¿´: 747 | »Ø¸´: 4 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
nieyingzhuifengľ³æ (ÕýʽдÊÖ)
|
[ÇóÖú]
·ÒëÒ»¾ä»°
|
|
| ´ó¼Ò°ïæ¿´Ò»¾ä»°£¬¡°°ÐÏòϸ°ûÑõ»¯»¹Ôµ÷¿ØµÄ¿¹Ö×ÁöÒ©Îïɸѡ¼°Æä¿¹°©»úÀíÑо¿¡±£¬ÄÜ·ñ·ÒëµÄºÃÒ»µã£¬Ð»Ð» |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ£¬³õÊԳɼ¨350Çóµ÷¼Á
ÒѾÓÐ14È˻ظ´
¸´ÊÔµ÷¼Á
ÒѾÓÐ4È˻ظ´
323·Ö£¨¼ÆËã»úÊÓ¾õºÍ´óÄ£ÐÍÏîÄ¿£©ÄÜÖ±½ÓÉÏÊÖ
ÒѾÓÐ3È˻ظ´
311·Ö 22408 Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
320·ÖÈ˹¤ÖÇÄܵ÷¼Á
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸Ö£´ó0705Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
0703»¯Ñ§
ÒѾÓÐ10È˻ظ´
301Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
306·Ö²ÄÁÏÓ뻯¹¤Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
vcheung098
Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 44
- Ó¦Öú: 567 (²©Ê¿)
- ½ð±Ò: 6061.6
- ºì»¨: 119
- Ìû×Ó: 1847
- ÔÚÏß: 369.4Сʱ
- ³æºÅ: 5569286
- ×¢²á: 2017-02-13
- רҵ: Ò©Îﻯѧ
2Â¥2017-04-11 12:16:36
genhunter
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 387
- Ó¦Öú: 259 (´óѧÉú)
- ½ð±Ò: 9757.4
- É¢½ð: 10
- ºì»¨: 60
- Ìû×Ó: 2484
- ÔÚÏß: 1793Сʱ
- ³æºÅ: 2558361
- ×¢²á: 2013-07-22
- רҵ: Ö×Áö»¯Ñ§Ò©ÎïÖÎÁÆ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
nieyingzhuifeng: ½ð±Ò+2, ¡ïÓаïÖú 2017-04-11 22:19:44
nieyingzhuifeng: ½ð±Ò+2, ¡ïÓаïÖú 2017-04-11 22:19:44
|
Screening and Antitumor Activity Mechanism Studies of Cell-Targeted (or Cell-Specific) Redox Modifying Antitumor Drugs or Screening and Antitumor Activity Mechanism Studies of a Cell-Targeted (or Cell-Specific) Redox Modifying Antitumor Drug |

3Â¥2017-04-11 14:31:27
nieyingzhuifeng
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 4343.2
- É¢½ð: 5
- ºì»¨: 3
- Ìû×Ó: 307
- ÔÚÏß: 157Сʱ
- ³æºÅ: 538070
- ×¢²á: 2008-04-02
- ÐÔ±ð: MM
- רҵ: ¿¹Ö×ÁöÒ©ÎïÒ©Àí
4Â¥2017-04-11 15:34:22
genhunter
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- ·ÒëEPI: 387
- Ó¦Öú: 259 (´óѧÉú)
- ½ð±Ò: 9757.4
- É¢½ð: 10
- ºì»¨: 60
- Ìû×Ó: 2484
- ÔÚÏß: 1793Сʱ
- ³æºÅ: 2558361
- ×¢²á: 2013-07-22
- רҵ: Ö×Áö»¯Ñ§Ò©ÎïÖÎÁÆ

5Â¥2017-04-12 07:45:44














»Ø¸´´ËÂ¥